Fresh Tracks Therapeutics Performance
FRTXDelisted Stock | USD 0.78 0.09 10.34% |
The firm shows a Beta (market volatility) of 0.44, which means possible diversification benefits within a given portfolio. As returns on the market increase, Fresh Tracks' returns are expected to increase less than the market. However, during the bear market, the loss of holding Fresh Tracks is expected to be smaller as well. Fresh Tracks Therapeutics right now shows a risk of 0.0%. Please confirm Fresh Tracks Therapeutics total risk alpha and the relationship between the downside variance and period momentum indicator , to decide if Fresh Tracks Therapeutics will be following its price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Fresh Tracks Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Fresh Tracks is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
Begin Period Cash Flow | 26.9 M |
Fresh |
Fresh Tracks Relative Risk vs. Return Landscape
If you would invest 78.00 in Fresh Tracks Therapeutics on October 26, 2024 and sell it today you would earn a total of 0.00 from holding Fresh Tracks Therapeutics or generate 0.0% return on investment over 90 days. Fresh Tracks Therapeutics is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than Fresh, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
Risk |
Fresh Tracks Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Fresh Tracks' investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Fresh Tracks Therapeutics, and traders can use it to determine the average amount a Fresh Tracks' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
FRTX |
Based on monthly moving average Fresh Tracks is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Fresh Tracks by adding Fresh Tracks to a well-diversified portfolio.
Fresh Tracks Fundamentals Growth
Fresh Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Fresh Tracks, and Fresh Tracks fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Fresh Pink Sheet performance.
Return On Equity | -0.81 | ||||
Return On Asset | -0.42 | ||||
Profit Margin | (0.89) % | ||||
Operating Margin | 0.25 % | ||||
Current Valuation | (4.04 M) | ||||
Shares Outstanding | 5.97 M | ||||
Price To Book | 0.45 X | ||||
Price To Sales | 0.48 X | ||||
Revenue | 6.94 M | ||||
EBITDA | (21.09 M) | ||||
Cash And Equivalents | 14.48 M | ||||
Cash Per Share | 5.04 X | ||||
Total Debt | 49 K | ||||
Debt To Equity | 0 % | ||||
Book Value Per Share | 1.85 X | ||||
Cash Flow From Operations | (19.34 M) | ||||
Earnings Per Share | (2.32) X | ||||
Total Asset | 10.27 M | ||||
Retained Earnings | (166.47 M) | ||||
About Fresh Tracks Performance
Evaluating Fresh Tracks' performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Fresh Tracks has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Fresh Tracks has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Fresh Tracks Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. Fresh Tracks Therapeutics, Inc. was founded in 2009 and is headquartered in Boulder, Colorado. Fresh Tracks operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 16 people.Things to note about Fresh Tracks Therapeutics performance evaluation
Checking the ongoing alerts about Fresh Tracks for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Fresh Tracks Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Fresh Tracks is not yet fully synchronised with the market data | |
Fresh Tracks has some characteristics of a very speculative penny stock | |
Fresh Tracks has a very high chance of going through financial distress in the upcoming years | |
The company reported the previous year's revenue of 6.94 M. Net Loss for the year was (21.1 M) with loss before overhead, payroll, taxes, and interest of (27.83 M). | |
Fresh Tracks Therapeutics currently holds about 14.48 M in cash with (19.34 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.04, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
- Analyzing Fresh Tracks' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Fresh Tracks' stock is overvalued or undervalued compared to its peers.
- Examining Fresh Tracks' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Fresh Tracks' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Fresh Tracks' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Fresh Tracks' pink sheet. These opinions can provide insight into Fresh Tracks' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Consideration for investing in Fresh Pink Sheet
If you are still planning to invest in Fresh Tracks Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Fresh Tracks' history and understand the potential risks before investing.
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |